No association has been established between increased plasma prolactin levels and breast cancer in man. However, a fraction, perhaps up to 30%, of human breast tumors may be prolactin-dependent. In patients susceptible to or bearing such tumors, the use of prolactin-stimulating antipsychotics may be relatively contraindicatd. Since such persons cannot yet be identified, no changes in current prescribing habits are suggested. As further biologic and epidemiologic data are obtained, however, their implications for clinical practice must be reevaluated.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Jan 1 1978|
ASJC Scopus subject areas
- Psychiatry and Mental health